Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures

NCT00327717 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Partial Seizures

Interventions

DRUG: Zonisamide
DRUG: Placebo

Sponsor

Eisai Inc.